Showing results (31-40 of 175) with videos related to
Sort By:
Pageof 18
Cancers|April 9, 2020
Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin LymphomaKristiina Karihtala, Suvi-Katri Leivonen, Oscar Brück, et al.Scientific Reports|August 4, 2022
The tumor and plasma cytokine profiles of renal cell carcinoma patientsMoon Hee Lee, Essi Laajala, Anna Kreutzman, et al.Clinical Immunology (Orlando, Fla.)|December 10, 2016
A novel class of somatic mutations in blood detected preferentially in CD8+ cellsMiko Valori, Lilja Jansson, Anna Kiviharju, et al.Experimental Hematology|June 5, 2012
Phosphoprotein profiling predicts response to tyrosine kinase inhibitor therapy in chronic myeloid leukemia patientsSari E Jalkanen, Anna-Maria Lahesmaa-Korpinen, Caroline A Heckman, et al.Cancer Immunology, Immunotherapy : CII|February 10, 2020
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patientsHenna Kasanen, Micaela Hernberg, Siru Mäkelä, et al.Plos One|January 31, 2017
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid LeukemiaMohamed El Missiry, Henrik Hjorth-Hansen, Johan Richter, et al.Haematologica|January 29, 2008
Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemiaTuija Lundán, Vesa Juvonen, Martin C Mueller, et al.Molecular Medicine (Cambridge, Mass.)|April 9, 2024
Single-cell characterisation of tissue homing CD4 + and CD8 + T cell clones in immune-mediated refractory arthritisDipabarna Bhattacharya, Jason Theodoropoulos, Katariina Nurmi, et al.Plos One|February 6, 2013
Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemiaLisa Christiansson, Stina Söderlund, Emma Svensson, et al.Leukemia Research|October 7, 2016
Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuliStina Söderlund, Lisa Christiansson, Inger Persson, et al.Pageof 18